Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial.
Kitchener HC, Almonte M, Thomson C, Wheeler P, Sargent A, Stoykova B, Gilham C, Baysson H, Roberts C, Dowie R, Desai M, Mather J, Bailey A, Turner A, Moss S, Peto J. Kitchener HC, et al. Among authors: baysson h. Lancet Oncol. 2009 Jul;10(7):672-82. doi: 10.1016/S1470-2045(09)70156-1. Epub 2009 Jun 17. Lancet Oncol. 2009. PMID: 19540162 Clinical Trial.
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.
Stringhini S, Wisniak A, Piumatti G, Azman AS, Lauer SA, Baysson H, De Ridder D, Petrovic D, Schrempft S, Marcus K, Yerly S, Arm Vernez I, Keiser O, Hurst S, Posfay-Barbe KM, Trono D, Pittet D, Gétaz L, Chappuis F, Eckerle I, Vuilleumier N, Meyer B, Flahault A, Kaiser L, Guessous I. Stringhini S, et al. Among authors: baysson h. Lancet. 2020 Aug 1;396(10247):313-319. doi: 10.1016/S0140-6736(20)31304-0. Epub 2020 Jun 11. Lancet. 2020. PMID: 32534626 Free PMC article.
Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in Switzerland.
West EA, Anker D, Amati R, Richard A, Wisniak A, Butty A, Albanese E, Bochud M, Chiolero A, Crivelli L, Cullati S, d'Acremont V, Epure AM, Fehr J, Flahault A, Fornerod L, Frank I, Frei A, Michel G, Gonseth S, Guessous I, Imboden M, Kahlert CR, Kaufmann L, Kohler P, Mösli N, Paris D, Probst-Hensch N, Rodondi N, Stringhini S, Vermes T, Vollrath F, Puhan MA; Corona Immunitas Research Group. West EA, et al. Int J Public Health. 2020 Dec;65(9):1529-1548. doi: 10.1007/s00038-020-01494-0. Epub 2020 Oct 24. Int J Public Health. 2020. PMID: 33098441 Free PMC article.
Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak.
Stringhini S, Zaballa ME, Perez-Saez J, Pullen N, de Mestral C, Picazio A, Pennacchio F, Wisniak A, Richard A, Baysson H, Loizeau A, Balavoine JF, Trono D, Pittet D, Posfay-Barbe K, Flahault A, Chappuis F, Kherad O, Vuilleumier N, Kaiser L, Azman AS, Guessous I; Specchio-COVID19 Study Group. Stringhini S, et al. Among authors: baysson h. Lancet Infect Dis. 2021 May;21(5):600-601. doi: 10.1016/S1473-3099(21)00054-2. Epub 2021 Feb 1. Lancet Infect Dis. 2021. PMID: 33539733 Free PMC article. No abstract available.
Risk of Reinfection After Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Population-based Propensity-score Matched Cohort Study.
Leidi A, Koegler F, Dumont R, Dubos R, Zaballa ME, Piumatti G, Coen M, Berner A, Darbellay Farhoumand P, Vetter P, Vuilleumier N, Kaiser L, Courvoisier D, Azman AS, Guessous I, Stringhini S; SEROCoV-POP study group. Leidi A, et al. Clin Infect Dis. 2022 Mar 1;74(4):622-629. doi: 10.1093/cid/ciab495. Clin Infect Dis. 2022. PMID: 34043763 Free PMC article.
Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland.
Stringhini S, Zaballa ME, Pullen N, de Mestral C, Perez-Saez J, Dumont R, Picazio A, Pennacchio F, Dibner Y, Yerly S, Baysson H, Vuilleumier N, Balavoine JF, Bachmann D, Trono D, Pittet D, Chappuis F, Kherad O, Kaiser L, Azman AS; SEROCoV-WORK + Study Group; Guessous I. Stringhini S, et al. Among authors: baysson h. Nat Commun. 2021 Jun 8;12(1):3455. doi: 10.1038/s41467-021-23796-4. Nat Commun. 2021. PMID: 34103517 Free PMC article.
Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study.
Richard A, Wisniak A, Perez-Saez J, Garrison-Desany H, Petrovic D, Piumatti G, Baysson H, Picazio A, Pennacchio F, De Ridder D, Chappuis F, Vuilleumier N, Low N, Hurst S, Eckerle I, Flahault A, Kaiser L, Azman AS, Guessous I, Stringhini S. Richard A, et al. Among authors: baysson h. Scand J Public Health. 2022 Feb;50(1):124-135. doi: 10.1177/14034948211048050. Epub 2021 Oct 19. Scand J Public Health. 2022. PMID: 34664529 Free PMC article.
Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021.
Stringhini S, Zaballa ME, Pullen N, Perez-Saez J, de Mestral C, Loizeau AJ, Lamour J, Pennacchio F, Wisniak A, Dumont R, Baysson H, Richard V, Lorthe E, Semaani C, Balavoine JF, Pittet D, Vuilleumier N, Chappuis F, Kherad O, Azman AS, Posfay-Barbe K, Kaiser L, Guessous I; Specchio-COVID19 study group. Stringhini S, et al. Among authors: baysson h. Euro Surveill. 2021 Oct;26(43):2100830. doi: 10.2807/1560-7917.ES.2021.26.43.2100830. Euro Surveill. 2021. PMID: 34713799 Free PMC article.
56 results